Showing results (271-280 of 464) with videos related to

Sort By:
Pageof 47
Blood|August 1, 1988
Epstein-Barr virus lymphoproliferation after bone marrow transplantationM M Zutter, P J Martin, G E Sale, et al.
Transplantation|November 1, 1992
Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetoneR F Raff, R Storb, T Graham, et al.
Haematology and Blood Transfusion|January 1, 1990
Supportive care of the marrow transplant recipient: the Seattle ExperienceK M Sullivan, J Meyers, F B Petersen, et al.
Blood|September 1, 1995
A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemiaP Kalhs, I Schwarzinger, G Anderson, et al.
Blood|October 1, 1992
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexateR A Nash, M S Pepe, R Storb, et al.
Blood|May 15, 1994
Unrelated donor or autologous marrow transplantation for treatment of acute leukemiaA Busca, C Anasetti, G Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1989
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remissionM S Tallman, K J Kopecky, D Amos, et al.
The New England Journal of Medicine|March 30, 1989
Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasmsK M Sullivan, R Storb, C D Buckner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factorsJ E Anderson, F R Appelbaum, G Schoch, et al.
Bone Marrow Transplantation|January 1, 1991
Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancyJ Nemunaitis, J W Singer, C D Buckner, et al.
Pageof 47